Epidemiology and risk factors for idiosyncratic drug-induced liver injury.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Björnsson, Einar SIssue Date
2014-05
Metadata
Show full item recordCitation
Semin. Liver Dis. 2014, 34 (2):115-22Abstract
Idiosyncratic drug-induced liver injury (DILI) is, like other adverse effects of drugs, underreported and underestimated in most epidemiological studies based on registries of DILI cases and reporting systems (e.g., Medwatch). The same is probably true for prospective population-based studies, although they are much more likely to mirror the true incidence of DILI. Despite these challenges, the epidemiology of DILI remains of utmost importance and is gradually coming into better focus. A recent population based study found a crude incidence of ∼19 cases per 100,000 per year. Certain agents are particularly noteworthy for their DILI risk. Amoxicillin-clavulanate continues to be the most commonly implicated agent occurring in ∼1 out of 2,300 users. Some others that standout with significantly higher risk include azathioprine and infliximab. Although statin-induced hepatotoxicity has been well documented, the risk is probably quite low. Overall, the majority of DILI in children and adults is associated with either antibiotics or anticonvulsants. Drug-induced liver injury associated with intravenously given drugs does not show any major differences from DILI due to orally administered agents. Unfortunately, our understanding of pretherapy risk assessment remains rudimentary for the most part.Description
To access publisher's full text version of this article click on the hyperlink at the bottom of the pageAdditional Links
http://dx.doi.org/10.1055/s-0034-1375953https://www.thieme-connect.com/DOI/DOI?10.1055/s-0034-1375953
Rights
Archived with thanks to Seminars in liver diseaseae974a485f413a2113503eed53cd6c53
10.1055/s-0034-1375953
Scopus Count
Collections
Related articles
- Drug-induced liver injury: an overview over the most critical compounds.
- Authors: Björnsson ES
- Issue date: 2015 Mar
- An update on drug induced liver injury.
- Authors: Rangnekar AS, Fontana RJ
- Issue date: 2011 Jun
- Drug-induced liver injury.
- Authors: Leise MD, Poterucha JJ, Talwalkar JA
- Issue date: 2014 Jan
- Hepatotoxicity by Drugs: The Most Common Implicated Agents.
- Authors: Björnsson ES
- Issue date: 2016 Feb 6
- Adverse drug reactions and organ damage: The liver.
- Authors: Licata A
- Issue date: 2016 Mar